Are there options for treating liver cancer? |. at 730

Research has found that there are satisfactory results in treating liver cancer through the latest non-invasive method “ultrasound tissue breakup” (Histotripsy) and it is expected to reduce the cost significantly.

Cardiovascular disease is the number one killer of people worldwide, with the exception of Hong Kong. Cancer is our leading cause of death. In addition, cancer has been on the rise among young people in recent years, and health-conscious friends need to increase their knowledge in this area. A little different from cardiovascular disease, our knowledge of cancer prevention is relatively low, but the cost of cancer treatment continues to reach high levels. As I said, prices and taxes are two different things. And prices are getting lower and lower What economics refers to is the decrease in effective medical prices as medical effects improve. Taking expensive but effective targeted therapy for example, the cost of effectively extending the lives of cancer patients is falling instead of rising. The question is, isn’t it better to be cheap but effective than to be expensive but effective?

Recently I was talking to a doctor friend about the latest treatment technology called histotripsy. Histo means soft tissue; Invented by a research team at the University of Michigan in 2004, the two together use the cavitation effect to create pressure around the device with ultrasonic energy and generate bubbles, which are then decomposed through rapid expansion and drop the bubbles and liquefy target device. The three “no’s” of non-invasive, non-ionic, and non-thermal ablation are the reasons for a quick recovery after treatment and a low risk of complications or recurrence. I’m not sure? A doctor friend explained to me that this is a new medical technology similar to HIFU, which relies heavily on physical energy rather than thermal energy to destroy tumors. Compared to HIFU, conceptual histotripsy may be more similar to lithotripsy stone shock treatment. After more than ten years of preclinical and clinical trials, ultrasonic tissue disruption was officially approved by the US Food and Drug Administration for the treatment of liver cancer at the end of last year. With safety and efficacy certification from the US FDA, economics is primarily concerned with cost effectiveness. The use of ultrasonic tissue fragmentation will go far beyond the treatment of liver cancer, and the cost of treatment currently only costs about US$8,000 (about HK$60,000), which is much lower than other traditional treatments that cost hundreds of thousands or even millions. Dr. Lu Chongmao and all the world-class liver specialists at the University of Hong Kong. When will cancer patients in Hong Kong have more options?